Indivior (LON:INDV) Shares Down 19.6% – What’s Next?

Indivior PLC (LON:INDV) shares traded down 19.6% on Thursday . The company traded as low as GBX 548.71 ($6.90) and last traded at GBX 697.50 ($8.78). 2,765,005 shares changed hands during trading, an increase of 277% from the average session volume of 733,828 shares. The stock had previously closed at GBX 868 ($10.92).

Analyst Ratings Changes

Separately, Jefferies Financial Group restated a “buy” rating and issued a GBX 1,800 ($22.65) price objective on shares of Indivior in a report on Tuesday, December 17th.

Indivior Stock Performance

The stock’s 50-day moving average price is GBX 928.06 and its 200 day moving average price is GBX 853.71. The company has a quick ratio of 1.52, a current ratio of 0.83 and a debt-to-equity ratio of -170.06. The company has a market cap of £1.09 billion, a P/E ratio of -580.40, a price-to-earnings-growth ratio of -5.57 and a beta of 0.19.

About Indivior

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.